0O
0OG.F OrganiGram Holdings Inc
- Market cap
- EUR 104M
- P/E
- 2.0x
- P/B
- 0.36x
- ROE
- 34.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to May 2026.
Is 0OG.F undervalued?
Graham numberThe Graham number of OrganiGram Holdings Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
OrganiGram Holdings Inc fundamental analysis
No fundamental analysis for OrganiGram Holdings Inc yet.
OrganiGram Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About OrganiGram Holdings Inc
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipp…
Full company profileOrganiGram Holdings Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to May 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
OrganiGram Holdings Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 987K | 6.13M | 5.71M | 12.4M | 80.4M | 86.8M | 79.2M | 146M | 160M | 259M | 305M |
| Gross Profit | 1.33M | 5.31M | -3.13M | 52.5M | 48.5M | -56.5M | -28.4M | 31.6M | 47.5M | 90.2M | 108M |
| Operating Income | -1.16M | 1.25M | -11.2M | 36.4M | 6.10M | -97.9M | -72.8M | -38.8M | -34.8M | -15.3M | -10.5M |
| EBITDA | - | - | -9.07M | 41.4M | 12.7M | -123M | - | 11.0M | -22.7M | 2.68M | 16.3M |
| Net Income | -1.28M | 847K | -10.9M | 20.5M | -9.54M | -136M | -131M | -14.3M | -45.4M | -24.8M | 166M |
| EPS | - | - | -0.11 | 0.16 | -0.06 | -0.70 | -1.75 | -0.18 | -0.42 | -0.18 | 1.18 |
| Balance Sheet | |||||||||||
| Total Assets | 14.2M | 53.9M | 92.8M | 303M | 429M | 435M | 554M | 577M | 408M | 562M | 820M |
| Total Liabilities | 6.32M | 9.61M | 9.78M | 118M | 102M | 136M | 74.2M | 69.0M | 102M | 213M | 335M |
| Shareholders' Equity | 7.85M | 44.3M | 83.0M | 185M | 327M | 300M | 480M | 508M | 306M | 349M | 485M |
| Cash & Short-term Investments | 1.47M | 9.86M | 1.96M | 55.1M | 47.6M | 24.6M | 55.4M | 68.5M | 107M | 28.2M | 10.9M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.77M | -1.77M | -9.27M | -12.7M | -35.1M | -45.1M | -28.6M | -36.2M | 3.87M | -7.59M | -36.1M |
| Capital Expenditure | 7.52M | 4.42M | 31.2M | 56.4M | 109M | 77.2M | 12.3M | 48.8M | 5.34M | 17.0M | 3.13M |
| Free Cash Flow | - | - | -40.4M | -69.1M | -145M | -124M | -40.9M | -85.0M | -1.47M | -24.6M | -38.7M |
| Ratios | |||||||||||
| ROE | -16.3% | 1.9% | -13.1% | 11.1% | -2.9% | -45.5% | -27.2% | -2.8% | -14.9% | -7.1% | 34.2% |
| ROA | -9.0% | 1.6% | -11.7% | 6.8% | -2.2% | -31.3% | -23.6% | -2.5% | -11.1% | -4.4% | 20.3% |
| Net Profit Margin | -129.4% | 13.8% | -190.6% | 165.0% | -11.9% | -156.9% | -165.1% | -9.8% | -28.4% | -9.6% | 54.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
OrganiGram Holdings Inc dividends
OrganiGram Holdings Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:4 on Jul 7, 2023.
Who owns OrganiGram Holdings Inc
- Insiders 19.63%
- Institutions 18.11%
- Public & others 62.26%
- Shares outstanding 299M
- Free float 240M
OrganiGram Holdings Inc company profile
- Company name
- OrganiGram Holdings Inc
- Ticker
- 0OG.F
- ISIN
- CA68617J1003
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 738
- Fiscal year end
- August
- Address
- 35 English Drive, Moncton, NB, Canada, E1E 3X3
- Phone
- 506 801 8986
- Website
- organigram.ca
About OrganiGram Holdings Inc
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
OrganiGram Holdings Inc management
10- Mr. Peter L. AmiraultExec. Chairman · born 1961
- Mr. Derrick W. West CPA, CPA, (CA)Chief Financial Officer · born 1967
- Ms. Helen MartinSr. VP of Strategic & Legal Affairs and Company Sec. · born 1978
- Mr. Gregory EngelSpecial Advisor · born 1965
- Mr. Paolo De Luca C.A., C.F.AChief Strategy Officer · born 1973
- Ms. Beena G. GoldenbergChief Exec. Officer
- Amy SchwalmVP of Investor Relations
- Ms. Megan Amber McCraeSr. VP of Marketing & Communications
- Mr. Timothy EmbergSr. VP of Sales & Commercial Operations
- Mr. James CavanaghChief of Staff